89bio Announces Q4 2023 and Full-Year Financial Results: In-Line GAAP EPS and Corporate Update

Thursday, 29 February 2024, 23:07

The financial report for 89bio's fourth quarter and full-year 2023 reveals an in-line GAAP EPS of -$0.50. The update also includes key insights into the company's performance and future strategies, providing investors with valuable information on 89bio's financial health and outlook.
LivaRava Finance Meta Image
89bio Announces Q4 2023 and Full-Year Financial Results: In-Line GAAP EPS and Corporate Update

89bio Financial Results:

The fourth-quarter and full-year 2023 financial results of 89bio (ETNB) have been released, showing an in-line GAAP EPS of -$0.50.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe